DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $97,298,705 | +0.7% | 442,441 | +9.9% | 0.34% | +6.5% |
| Q2 2023 | $96,633,600 | -22.1% | 402,640 | -18.2% | 0.32% | -24.8% |
| Q1 2023 | $124,030,395 | -4.1% | 492,106 | +1.0% | 0.43% | -8.4% |
| Q4 2022 | $129,268,565 | -46.5% | 487,034 | -48.0% | 0.47% | -1.9% |
| Q3 2022 | $241,725,931 | -5.4% | 935,870 | -7.2% | 0.48% | +0.2% |
| Q2 2022 | $255,550,094 | -16.2% | 1,008,008 | -3.0% | 0.47% | +9.5% |
| Q1 2022 | $304,858,228 | +67.6% | 1,039,302 | +88.0% | 0.43% | -6.9% |
| Q4 2021 | $181,857,000 | +10.0% | 552,740 | +1.8% | 0.46% | +0.2% |
| Q3 2021 | $165,263,000 | -41.5% | 542,839 | -48.4% | 0.46% | +14.3% |
| Q2 2021 | $282,538,000 | +135.5% | 1,052,828 | +97.5% | 0.41% | +11.2% |
| Q1 2021 | $119,958,000 | -0.6% | 532,956 | -1.9% | 0.36% | -3.7% |
| Q4 2020 | $120,723,000 | +5.6% | 543,453 | +2.4% | 0.38% | -8.2% |
| Q3 2020 | $114,330,000 | -10.9% | 530,951 | -26.9% | 0.41% | +63.2% |
| Q2 2020 | $128,384,000 | +15.9% | 726,034 | -9.3% | 0.25% | -8.7% |
| Q1 2020 | $110,812,000 | -34.6% | 800,610 | -27.5% | 0.28% | -19.7% |
| Q4 2019 | $169,414,000 | +9.9% | 1,103,814 | +3.4% | 0.34% | +12.4% |
| Q3 2019 | $154,176,000 | +7.1% | 1,067,496 | +6.0% | 0.31% | +8.9% |
| Q2 2019 | $143,934,000 | +118.1% | 1,007,098 | +101.5% | 0.28% | +9.3% |
| Q1 2019 | $65,998,000 | +19.3% | 499,908 | -6.8% | 0.26% | +7.1% |
| Q4 2018 | $55,319,000 | -9.1% | 536,444 | -4.2% | 0.24% | +8.1% |
| Q3 2018 | $60,844,000 | -26.0% | 559,952 | -32.8% | 0.22% | -29.2% |
| Q2 2018 | $82,263,000 | +2.6% | 833,632 | +1.8% | 0.32% | -1.6% |
| Q1 2018 | $80,200,000 | -3.9% | 819,123 | -8.9% | 0.32% | -2.4% |
| Q4 2017 | $83,470,000 | +7.3% | 899,266 | -0.8% | 0.33% | -2.1% |
| Q3 2017 | $77,798,000 | +3.5% | 906,949 | +1.9% | 0.34% | -1.8% |
| Q2 2017 | $75,140,000 | -2.3% | 890,384 | -0.9% | 0.34% | -1.7% |
| Q1 2017 | $76,872,000 | +7.8% | 898,774 | -1.9% | 0.35% | +3.6% |
| Q4 2016 | $71,320,000 | +4.5% | 916,247 | +5.2% | 0.34% | +11.7% |
| Q3 2016 | $68,260,000 | -17.2% | 870,769 | +6.7% | 0.30% | -18.3% |
| Q2 2016 | $82,431,000 | +5.6% | 816,144 | -0.8% | 0.37% | +4.9% |
| Q1 2016 | $78,045,000 | -5.2% | 822,740 | -7.2% | 0.35% | -2.8% |
| Q4 2015 | $82,358,000 | +11.1% | 886,716 | +1.9% | 0.36% | +18.4% |
| Q3 2015 | $74,123,000 | -0.4% | 869,884 | +0.1% | 0.30% | +2.0% |
| Q2 2015 | $74,406,000 | -28.3% | 869,328 | -28.8% | 0.30% | -30.2% |
| Q1 2015 | $103,723,000 | +44.0% | 1,221,713 | +45.4% | 0.43% | +47.8% |
| Q4 2014 | $72,006,000 | +9.5% | 840,108 | -3.0% | 0.29% | +2.8% |
| Q3 2014 | $65,782,000 | -4.4% | 865,769 | -0.9% | 0.28% | -1.7% |
| Q2 2014 | $68,783,000 | +8.6% | 873,659 | +3.4% | 0.29% | +3.6% |
| Q1 2014 | $63,354,000 | -2.5% | 844,709 | +0.3% | 0.28% | -5.2% |
| Q4 2013 | $64,997,000 | +11.2% | 841,930 | -0.2% | 0.29% | +1.0% |
| Q3 2013 | $58,450,000 | -0.0% | 843,200 | -8.7% | 0.29% | -7.4% |
| Q2 2013 | $58,453,000 | – | 923,428 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |